VTN and systemic lupus erythematosus: In healthy individuals, ICs are bound by complement proteins and are quickly cleared [42]; however, many SLE patients have defects in one or more complement pathway components [43], leading to reduced clearance of ICs and resultant type III hypersensitivity [44].